(IN BRIEF) Empa has developed polymer-based, MRI-compatible electrode cables in collaboration with Swiss company TI Solutions AG, addressing long-standing safety and performance challenges associated with using conductive materials inside MRI scanners. By replacing traditional copper wiring with polymer fibers coated … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged Advanced Fibers laboratory, diagnostic technology, Dirk Hegemann, ECG, EEG, Empa, Empa Introduces Scalable Polymer Fiber Cables Designed for Safe Use in MRI Environments, Innosuisse, magnetic resonance imaging, magnetron sputtering, medical imaging, medical research, MRI, MRI-compatible cables, neurostimulation, Niels Kuster, polymer cables, silver titanium coating, Sven Kühn, temporal interference stimulation, TI Solutions AG
(IN BRIEF) EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, led through the LSP Dementia … Read the full press release
Posted in Healthcare, Investment, Pharma & Biotech, Sweden
Tagged agitation, Alzheimer’s disease, Andera Partners, dementia care, Deraphan, EQT Life Sciences, Exciva, Exciva Raises €51 Million Series B to Support Phase 2 Trial for Alzheimer’s Agitation Treatment, Fountain Healthcare Partners, Gimv, Juliette Lee, LBBW, LifeArc, LSP Dementia Fund, neuropsychiatric symptoms, neuroscience therapeutics, Phase 2 clinical trial, Philip Scheltens, Series B financing
(IN BRIEF) GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, while GSK maintains a 78.3 percent majority holding. The transaction, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biopharma partnership, cabotegravir, David Redfern, dolutegravir, GSK, HIV prevention, HIV treatment, integrase inhibitors, John Keller, long acting injectables, Pfizer, pharmaceutical industry, shareholder restructuring, Shionogi, strategic investment, ViiV Healthcare, ViiV Healthcare Ownership Streamlined with Expanded Shionogi Investment and GSK Majority
(IN BRIEF) GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its Respiratory, Immunology & Inflammation pipeline. Designed to offer sustained … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged anti IgE therapy, biopharmaceutical acquisition, Brian Wong, clinical-stage biotech, Food allergy, GSK, GSK Expands Food Allergy Portfolio with Acquisition of RAPT and Ozureprubart Asset, Healthcare Innovation, immunology, monoclonal antibody, ozureprubart, pediatric allergy, phase IIb trial, prestIgE study, RAPT Therapeutics, respiratory and inflammation pipeline, Tony Wood
(IN BRIEF) Fresenius and SAP have announced plans to form a strategic partnership to accelerate digital innovation in healthcare and establish a sovereign, interoperable, and AI-supported healthcare ecosystem. By combining Fresenius’ global healthcare expertise with SAP’s digital platforms and AI … Read the full press release
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI in healthcare, AnyEMR, Christian Klein, data sovereignty, digital healthcare, digital transformation, electronic medical records, European healthcare innovation, Fresenius, HL7 FHIR, hospital information systems, interoperable healthcare systems, Michael Sen, SAP, SAP Business AI, SAP Business Data Cloud, SAP Business Suite, SAP Business Technology Platform, Strategic Fresenius–SAP Collaboration Targets AI-Supported Healthcare Transformation, strategic partnership
(IN BRIEF) ZEISS Medical Technology is presenting its advanced dental visualization solutions at AEEDC in Dubai, featuring medical loupes and dental microscopes designed to enhance precision, ergonomics, and workflow efficiency in dental practices. The showcased portfolio includes the EyeMag® Family … Read the full press release
Posted in Business, Electronics & Machinery, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, Pharma & Biotech, Science, Technology
Tagged AEEDC Dubai, Carl Zeiss Meditec AG, Christoph Schaeff, dental microscopes, dental visualization, dental workflows, digital dentistry, Dr Marc Habib, Dr Tetsuya Uchiyama, endodontics, ergonomic dentistry, EXTARO 300, EyeMag family, medical loupes, microdentistry, OPMI PROergo, ZEISS Medical Technology, ZEISS Presents Comprehensive Visualization Solutions for Modern Dental Practices at AEEDC in Dubai
(IN BRIEF) Sanofi has secured regulatory approval in China for two innovative medicines, Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome. The approvals expand treatment options for patients with serious cardiovascular and rare metabolic diseases and underscore … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Security & Safety, Technology
Tagged aficamten, cardiovascular disease, China NMPA, clinical phase 3 trials, familial chylomicronemia syndrome, FCS, Greater China, innovative medicines, Myqorzo, obstructive hypertrophic cardiomyopathy, oHCM, Olivier Charmeil, plozasiran, rare diseases, Redemplo, Sanofi, Sanofi Strengthens China Portfolio with Approval of Two Innovative Therapies for oHCM and FCS, siRNA therapy
(IN BRIEF) Boehringer Ingelheim has been awarded the Global Top Employer 2026 certification by the Top Employers Institute for the sixth consecutive year, reinforcing its long-standing commitment to employee well-being and an attractive work environment. The recognition highlights strong performance … Read the full press release
Posted in Germany, Healthcare, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged Boehringer Ingelheim, Boehringer Ingelheim Earns Global Top Employer 2026 Recognition for Sixth Consecutive Year, career development, employee well-being, employer branding, flexible working, Global Top Employer 2026, human resources, learning and development, Michael Schmelmer, People Strategy, physical mental social financial health, rewards and recognition, Top Employers Institute, Work Environment, workplace culture
(IN BRIEF) SCHOTT Pharma has pre-validated its SCHOTT TOPPAC® ISO-standardized polymer cartridge for compatibility with SHL Medical’s Maggie® large-volume autoinjector platform. The collaboration delivers a ready-to-use, de-risked solution for administering highly sensitive biologics in large volumes, supporting self-injection and home-care … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, biologics administration, biosimilars, cell and gene therapy delivery, home care drug delivery, ISO standardized cartridge, large volume drug delivery, Maggie autoinjector, Markus Puusepp, pharmaceutical packaging, polymer cartridge, ready to use packaging, SCHOTT iQ platform, SCHOTT Pharma, SCHOTT Pharma Pre-Validates Polymer Cartridge with SHL Medical’s Maggie Autoinjector Platform, SCHOTT TOPPAC, SCHOTT TOPPAC Polymer Cartridge Achieves Compatibility with SHL Medical Large-Volume Autoinjectors, self injection devices, SHL Medical
(IN BRIEF) GEA is equipping the new Veterinary Vaccine Institute in Huambo, Angola, with advanced separation and aseptic valve technology, including a CSC 6 disc centrifuge, a CIP system and GEA VESTA® sterile valves. Scheduled for commissioning in autumn 2026, … Read the full press release
Posted in Agriculture, Business, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Pharma & Biotech, Science, Technology
Tagged agricultural development Angola, Angola vaccine production, animal vaccines Africa, aseptic processing technology, biopharmaceutical equipment, bioveterinary centre, cGMP compliant equipment, CIP SIP processing, Clean in Place system, CSC 6 disc centrifuge, GAUFF Engineering, GEA, GEA Hydrostop, GEA Supplies Advanced Separation Technology for New Veterinary Vaccine Institute in Angola, GEA Technology to Power New Veterinary Vaccine Centre in Huambo Angola, GEA VESTA sterile valves, hydrohermetic feed system, MINAGRIF, Ministry of Agriculture and Forestry Angola, NORÁFRICA, Veterinary Vaccine Institute Huambo
(IN BRIEF) The European Investment Bank, via EIB Global, has invested $37.5 million in Alta Semper Fund II to support pharmaceutical, life sciences and MedTech companies across Africa, with a primary focus on North Africa. The fund is expected to … Read the full press release
Posted in Banks, Business, European Union, Financial, Healthcare, Internet & Online, Investment, Luxembourg, News, Pharma & Biotech
Tagged Afsane Jetha, Alta Semper Capital, Alta Semper Fund II, Cheick Oumar Sylla, EIB Commits $37.5 Million to Alta Semper Fund II to Boost Healthcare Investment in Africa, EIB Global, EIB Investment in Alta Semper Fund II Aims to Catalyse $150 Million for African Healthcare Sector, EU Africa cooperation, EU Global Health Strategy, European Investment Bank, Gelsomina Vigliotti, gender equality investment, Global Gateway, Healthcare Innovation, healthcare investment Africa, life sciences investment, MedTech investment, North Africa healthcare, pharmaceutical sector Africa, private equity Africa, Rania Al Mashat, women led funds
(IN BRIEF) DNV has partnered with Korean diagnostics company Noul to certify its AI-powered malaria, blood cell and cervical cancer testing solutions under the EU In Vitro Diagnostic Medical Device Regulation. Acting as an IVDR Notified Body, DNV will assess … Read the full press release
Posted in Artificial Intelligence (AI), Business, Healthcare, Industrial, Management, News, Norway, Pharma & Biotech, Technology
Tagged AI diagnostics, blood cell morphology, CE marking, Cecilie Gudesen Torp, cervical cancer testing, diagnostic technology, DNV, DNV and Noul Collaborate to Advance EU Certification for AI-Powered Medical Diagnostics, DNV to Support IVDR Certification of Noul’s miLab Diagnostic Platform, EU Medical Device Regulation, Healthcare Innovation, in vitro diagnostic devices, IVDR certification, malaria diagnosis, medical device certification, miLab platform, Noul, point of care diagnostics, Taehwan Kim
(IN BRIEF) Basilea Pharmaceutica has partnered with INCATE, the European incubator for antibacterial therapies, to support the advancement of early-stage anti-infective innovations. As an industry partner, Basilea brings deep expertise in antibacterial and antifungal drug development, while expanding INCATE’s scope … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Non Profit, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged anti-infectives, antibacterial therapies, antifungal therapies, antimicrobial resistance, Basel life sciences, Basilea Joins INCATE to Advance Early-Stage Antibacterial and Antifungal Innovation in Europe, Basilea Pharmaceutica, biopharmaceutical innovation, clinical development, drug development, INCATE, industry partnership, infectious diseases, invasive fungal infections, Laurenz Kellenberger, preclinical research, Primo Schär, University of Basel
(IN BRIEF) Researchers at the Luxembourg Institute of Health have published a major review in Nature Cancer proposing a new framework to explain and potentially overcome the long-standing resistance of glioblastoma to immunotherapy. The study analyses how this aggressive brain … Read the full press release
Posted in Education, Healthcare, Industrial, Luxembourg, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged brain cancer, cancer immunology, cancer research, Department of Cancer Research, glioblastoma, immune plasticity, immune resistance, immunotherapy, LIH, Luxembourg Institute of Health, Nature Cancer, Nature Cancer Review Reveals Why Immunotherapy Fails in Glioblastoma and How to Rethink Treatment, neuro-oncology, NORLUX Neuro-Oncology Laboratory, NORLUX Scientists Propose Immune Microenvironment Framework for Next-Generation Glioblastoma Therapies, oncology innovation, T cells, tumour microenvironment, tumour-associated macrophages
(IN BRIEF) EQT Life Sciences has exited its investment in Vivasure Medical following the sale of the Irish medical technology company to Haemonetics. Backed by EQT since 2016, Vivasure developed the PerQseal® Elite system, a bioabsorbable, sutureless solution for large-bore … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Ireland, Management, Pharma & Biotech, Science, Sweden, Technology
Tagged Anne Portwich, endovascular interventions, EQT Life Sciences, EQT Life Sciences Exits Vivasure Medical Following Sale to Haemonetics, Galway Ireland, Haemonetics, healthcare investment, life sciences, LSP Health Economics Fund, medical technology, PerQseal Elite, structural heart procedures, vessel closure systems, Vivasure Medical
(IN BRIEF) EQT Life Sciences has invested in U.S.-based Kinaset Therapeutics as part of a USD 103 million oversubscribed Series B financing. The funding will support the clinical advancement of frevecitinib, a novel inhaled pan-JAK inhibitor designed to treat a … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Sweden, Technology
Tagged asthma treatment, biopharmaceuticals, clinical-stage biotech, Daniela Begolo, EQT Life Sciences, EQT Life Sciences Backs Kinaset Therapeutics in USD 103m Series B Financing, Forge Life Science Partners, frevecitinib, inhaled therapeutics, Kinaset Therapeutics, pan-JAK inhibitor, RA Capital Management, respiratory diseases, Series B financing
(IN BRIEF) The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported by TN-10 phase 2 … Read the full press release
Posted in Business, European Union, Financial, France, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Security & Safety, Technology
Tagged autoimmune disease, beta cell function, CHMP, clinical approval, disease modifying therapy, EMA, European Commission, Sanofi, Sanofi’s Teizeild Becomes First EU-Approved Therapy to Delay Type 1 Diabetes Progression, T1D, Teizeild, teplizumab, TN-10 study, type 1 diabetes
(IN BRIEF) ShanX Medtech, a spin-off from Eindhoven University of Technology, has raised €24 million in combined public and private funding to accelerate the development of its ultra-rapid antimicrobial susceptibility testing platform. The financing includes an oversubscribed €15 million seed … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged AMR, antimicrobial resistance, antimicrobial susceptibility testing, Ardjan van der Linden, AST, Borski Fund, Brabant Development Agency, Eindhoven University of Technology, European Commission funding, HADEA, Hera, High Tech Campus Eindhoven, In Vitro Diagnostics, Invest-NL, Jaap den Toonder, MedTech innovation, New €24 Million Investment Positions ShanX Medtech for Clinical Launch of Rapid AST Technology, ShanX Medtech, Sophia E Shanko, TU/e spin-off
(IN BRIEF) Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The partnership focuses on novel compounds with a new mode of action aimed at pathogens such … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Switzerland, Technology
Tagged anti-infective research, antifungal drug development, Aspergillus, Basilea Partners with Prokaryotics to Develop Novel Broad-Spectrum Antifungal Therapy, Basilea Pharmaceutica, biopharmaceutical collaboration, Candida, clinical development, first in class antifungal, global licensing agreement, invasive fungal infections, Laurenz Kellenberger, novel mode of action, Prokaryotics, rare molds, Terry Roemer
(IN BRIEF) GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s Ministry of Health, Labour and Welfare, the therapy delivers sustained disease control … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ANCHOR trials, asthma exacerbations, chronic rhinosinusitis with nasal polyps, CRSwNP, Depemokimab, Exdensur, Exdensur Gains Approval in Japan, Expanding GSK’s Respiratory Biologic Portfolio, GSK, GSK’s Depemokimab Approved in Japan, interleukin 5, Introducing New Option for Severe Asthma Care, Japan Ministry of Health Labour and Welfare, Kaivan Khavandi, Nasal Polyps, respiratory medicine, Severe Asthma, SWIFT trials, type 2 inflammation, ultra long acting biologic
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?